In the May 2004 issue:
UnitedHealth Group Buys Oxford Health
Plan for $4.9 Billion
Not content to watch Anthem and WellPoint overtake it as the country’s
largest health insurer, UnitedHealth Group is paying $4.9 billion to buy
Oxford Health Plans and establish a beachhead in the Northeast.
...
The Month in Deals
Sixty-six health care deals were announced over the past four weeks. Based
on revealed prices, a total of $8.5 billion was committed to finance them.
...
Trends of the Month
Hospital companies engaged in deal making in the Behavioral Health,
Hospital, Laboratory and Managed Care sectors. Are they trying to reassert
their role as hub of the health care delivery system?
As Sanofi upped its offer for Aventis, and Aventis accepted,
Pharmaceutical M&A activity took a breather.
...
In The Departments
Deal Summaries
Additional Transactions
Transaction Updates
Sign
up for a trial subscription and get the current issue!
Read more about
The
Health Care M&A Monthly. Read the past
headlines. |
UnitedHealth Group Buys Oxford Health
Plan for $4.9 Billion Rumors in the M&A market often
contain a grain of truth. Last
month, for example, we wrote that New York’s newly public WellChoice
(NYSE: WC) was said to be in negotiations to buy Oxford Health Plans
(NYSE: OHP) in an all-stock deal. WC admitted to holding talks only after
the two companies decided to walk away from the deal.
Far from dampening the desire to speculate about deals,
the lack of concrete information usually fires the imagination of the
punditry, and this case was no different. The media abounded with
estimates about price (these pages calculated $5.1 billion), concerns over
antitrust rules and scenarios for strategic fit. In the babble of voices,
one analyst at Fitch Ratings, Doug Meyer, may have understated the
case when he said, "Don’t count UnitedHealth out."
Four days after WellChoice’s announcement of a no-go,
UnitedHealth Group (NYSE: UNH) stepped in with a $4.9 billion offer
to buy Oxford. It appears that UNH is not prepared to sit quietly on the
sidelines as Anthem (NYSE: ATH) and WellPoint Health Networks
(NYSE: WLP) rush to capture the title of the nation’s largest MCO.
Until the Anthem-WellPoint deal closes, Minnesota-based
UNH is still the country’s largest health insurer with 20.2 million
members. On a trailing 12-month basis, UNH generated revenue of $29
billion, EBITDA of $3 billion and net income of $1.8 billion.
An avid acquirer, UNH recently bolstered its East Coast
operations in February with the $2.95 billion acquisition of Mid
Atlantic Medical Services (NYSE: MME) and its 2 million members. What
UNH found attractive in that deal was MME’s roster of big clients, which
includes Sears, Roebuck and Co., Target Corp., Verizon
and Wachovia Corp.
Based in Trumbull, Connecticut, Oxford Health Plans
currently serves 1.5 million plan enrollees in the New York City
metropolitan area, including neighboring Connecticut and New Jersey. On a
trailing 12-month basis, OHP generated revenue of $5.45 billion, EBITDA of
$633 million and net income of $352 million.
It was not always so rosy. In the last decade Oxford
had ambitions of becoming a national player, and had even acquired
operations in Florida, New Hampshire and Pennsylvania. But OHP seriously
stumbled in October 1997 when it announced that due to billing mistakes
and delays in processing claims, it would generate a loss. That caused the
stock to lose 67% of its value in one day. After management cut costs (but
not premiums) and sold off unprofitable businesses (the Florida, New
Hampshire and Pennsylvania plans all went in 1998 along with the New
Jersey Medicaid business), the company started its long and steady climb
back to financial health.
Under terms of the deal, OHP shareholders are to
receive 0.6357 shares of UNH stock and $16.17 in cash for each share of
OHP common stock they hold. UNH would end up issuing about 34,773,000
million shares of its stock and pay out $1.4 billion in cash. This works
out to a purchase price of approximately $4.9 billion.
This price implies a price to revenue (P/R) multiple of
0.9x, price to EBITDA of 7.75x and price per enrollee of $3,267. It
further represents a 14% premium to the closing price of OHP stock the day
before the deal was announced. Apparently Oxford’s board liked the cash
component in UNH’s deal better than the all-stock consideration in the
proposal by WellChoice, a company with scant history in the public
markets.
UnitedHealth’s primary interest in seeing this deal
done is to strengthen the company’s position in the New York metropolitan
market, one of the country’s densest and potentially most profitable. The
increased capacity from the Oxford acquisition would help UNH provide a
broader range of services to the 43 large, multisite employers based in
the tristate area that UNH already serves. And with 90 Fortune 500
companies headquartered in the region, UNH will doubtlessly seek to parlay
its expertise with large employer groups into new contracts.
Any deal this big naturally comes with a slew of
advisors and bankers. UNH was advised by J.P. Morgan Chase & Co.,
Morgan Stanley, Citigroup, Inc. and Bank of America Corp.,
while Skadden Arps Slate Meagher & Flom LLP and Dorsey & Whitney
LLP provided legal counsel. On Oxford’s team, legal counsel was
provided by Sullivan & Cromwell LLP while Goldman Sachs & Co.
acted as financial advisor.
This merger will put WellChoice, Aetna (NYSE:
AET) and Cigna Corp. (NYSE: CI) on the defensive in the Northeast.
New enrollment has largely stalled for these companies, so one of the few
ways left to bulk up is through the acquisition of other plans. This deal
may help drive home the logic of buy, or be bought.
On a national scale, by closing the enrollment gap with soon-to-be
number one Anthem-WellPoint, UnitedHealth has signaled its willingness to
make acquisitions so it can enjoy the benefits conferred by being number
one.
|